317 related articles for article (PubMed ID: 33591542)
1. Atopic Dermatitis: A Patient and Dermatologist's Perspective.
Berruyer M; Delaunay J
Dermatol Ther (Heidelb); 2021 Apr; 11(2):347-353. PubMed ID: 33591542
[TBL] [Abstract][Full Text] [Related]
2. Towards a patient-centred definition for atopic dermatitis flare: a qualitative study of adults with atopic dermatitis.
Dainty KN; Thibau IJC; Amog K; Drucker AM; Wyke M; Begolka WS
Br J Dermatol; 2024 Jun; 191(1):82-91. PubMed ID: 38287887
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
4. At the Dawn of a Therapeutic Revolution for Atopic Dermatitis: An Interview with Dr Anne-Claire Fougerousse.
Fougerousse AC
Dermatol Ther (Heidelb); 2021 Apr; 11(2):331-338. PubMed ID: 33523410
[TBL] [Abstract][Full Text] [Related]
5. Erythrodermic Presentation of Atopic Dermatitis in a Patient with Secondary Adrenal Insufficiency Caused by Oral Glucocorticosteroid Abuse.
Mesjasz A; Trzeciak M; Sroka-Tomaszewska J; Zaryczańska A; Nowicki RJ
Acta Dermatovenerol Croat; 2023 Nov; 31(2):103-105. PubMed ID: 38006372
[TBL] [Abstract][Full Text] [Related]
6. Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis.
Anderson P; Austin J; Lofland JH; Piercy J; Joish VN
Dermatol Ther (Heidelb); 2021 Oct; 11(5):1571-1585. PubMed ID: 34268709
[TBL] [Abstract][Full Text] [Related]
7. Development of a Patient Journey Map for Improving Patient Experience and Quality of Atopic Dermatitis Care.
Roustán G; Loro M; Rosell Á; Menchen B; Vicente O; Elosua-González M; Castaño JL; Peña C; Isidoro O
Dermatol Ther (Heidelb); 2024 Feb; 14(2):505-519. PubMed ID: 38334904
[TBL] [Abstract][Full Text] [Related]
8. Atopic Dermatitis and the Medications Used for its Management: Impact on Ocular Health.
Beakes C; Briceno L
J Drugs Dermatol; 2022 May; 21(5):523-525. PubMed ID: 35533031
[TBL] [Abstract][Full Text] [Related]
9. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
Zímová J; Zímová P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
[TBL] [Abstract][Full Text] [Related]
10. Atopic dermatitis in children.
Arkwright PD; Stafford JC; Sharma V
J Allergy Clin Immunol Pract; 2014; 2(4):388-95. PubMed ID: 25017525
[TBL] [Abstract][Full Text] [Related]
11. Physician Perception of Disease Severity and Treatment Outcomes for Children and Adolescents with Atopic Dermatitis in Emerging Economies.
Tang MBY; Fatani M; Wiggins S; Maspero J
Dermatol Ther (Heidelb); 2022 Apr; 12(4):999-1013. PubMed ID: 35349107
[TBL] [Abstract][Full Text] [Related]
12. Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France.
Foudrat E; Caillard S
Infect Dis Ther; 2024 Mar; 13(3):439-445. PubMed ID: 38457110
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous resolution of atopic dermatitis incidental to participation in benralizumab clinical trial for severe, uncontrolled asthma: a case report.
Pham DN
J Med Case Rep; 2021 Mar; 15(1):103. PubMed ID: 33673870
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
[TBL] [Abstract][Full Text] [Related]
15. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
[TBL] [Abstract][Full Text] [Related]
16. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults.
Barrett A; Hahn-Pedersen J; Kragh N; Evans E; Gnanasakthy A
Patient; 2019 Oct; 12(5):445-459. PubMed ID: 31270775
[TBL] [Abstract][Full Text] [Related]
17. Treatment of adult atopic dermatitis patients according to disease characteristics and demographics.
Thyssen JP; Andersen YMF; Vittrup I; Pierce E; DeLozier A; Egeberg A
Dermatol Ther; 2020 Nov; 33(6):e14439. PubMed ID: 33084105
[TBL] [Abstract][Full Text] [Related]
18. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.
Wollenberg A; Christen-Zäch S; Taieb A; Paul C; Thyssen JP; de Bruin-Weller M; Vestergaard C; Seneschal J; Werfel T; Cork MJ; Kunz B; Fölster-Holst R; Trzeciak M; Darsow U; Szalai Z; Deleuran M; von Kobyletzki L; Barbarot S; Heratizadeh A; Gieler U; Hijnen DJ; Weidinger S; De Raeve L; Svensson Å; Simon D; Stalder JF; Ring J;
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2717-2744. PubMed ID: 33205485
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
[TBL] [Abstract][Full Text] [Related]
20. Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A.
Andersen L; Nyeland ME; Nyberg F
Br J Dermatol; 2020 May; 182(5):1176-1183. PubMed ID: 31437300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
